Search research articles
Contact Us
Filters
Showing results (281-290 of 302) with videos related to
Page
of 31
Sort By:
Cancer Chemotherapy and Pharmacology
|
April 12, 2011
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study
Ticiana B Leal, Scot C Remick, Chris H Takimoto, et al.
Journal of the American College of Cardiology
|
July 14, 2001
Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME)
D A Morrison, G Sethi, J Sacks, et al.
Clinical Colorectal Cancer
|
March 18, 2021
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors
Koji Ando, Al Ozonoff, Shin-Yin Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
A Patnaik, L J Appleman, A W Tolcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2013
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer
Colin D Weekes, Daniel D Von Hoff, Alex A Adjei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group
Joseph Gibbons, Merrill J Egorin, Ramesh K Ramanathan, et al.
Plos One
|
February 4, 2014
Integrated genomic and epigenomic analysis of breast cancer brain metastasis
Bodour Salhia, Jeff Kiefer, Julianna T D Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2007
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07
J Philip Kuebler, H Samuel Wieand, Michael J O'Connell, et al.
The New England Journal of Medicine
|
October 18, 2013
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, et al.
Investigational New Drugs
|
February 12, 2013
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
Glen J Weiss, Joseph Chao, Jeffrey D Neidhart, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 302) with videos related to
Sort By:
Page
of 31
Cancer Chemotherapy and Pharmacology
|
April 12, 2011
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study
Ticiana B Leal, Scot C Remick, Chris H Takimoto, et al.
Journal of the American College of Cardiology
|
July 14, 2001
Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME)
D A Morrison, G Sethi, J Sacks, et al.
Clinical Colorectal Cancer
|
March 18, 2021
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors
Koji Ando, Al Ozonoff, Shin-Yin Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 28, 2016
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
A Patnaik, L J Appleman, A W Tolcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2013
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer
Colin D Weekes, Daniel D Von Hoff, Alex A Adjei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group
Joseph Gibbons, Merrill J Egorin, Ramesh K Ramanathan, et al.
Plos One
|
February 4, 2014
Integrated genomic and epigenomic analysis of breast cancer brain metastasis
Bodour Salhia, Jeff Kiefer, Julianna T D Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2007
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07
J Philip Kuebler, H Samuel Wieand, Michael J O'Connell, et al.
The New England Journal of Medicine
|
October 18, 2013
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, et al.
Investigational New Drugs
|
February 12, 2013
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
Glen J Weiss, Joseph Chao, Jeffrey D Neidhart, et al.
Page
of 31